Kidney dysfunction in the recipients of liver transplants

被引:52
作者
Wilkinson, A [1 ]
Pham, PT [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Kidney & Pancreas Transplant Program, Los Angeles, CA 90095 USA
关键词
D O I
10.1002/lt.20618
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1. Pretransplant kidney function is an important predictor of posttransplant kidney function. 2. Chronic kidney disease is present in 20% of liver transplant recipients by 5 years. 3. Kidney function is impacted by pretransplant management of the consequences of the hepatorenal syndrome. 4. The use of calcineurin inhibitor (CNI) - based immunosuppression is an important factor in the development of chronic kidney disease, and the use of mycophcnolic acid- or sirolimus-based immunosuppression with reduced-dose CNI may be of benefit.
引用
收藏
页码:S47 / S51
页数:5
相关论文
共 34 条
[1]   Comparison of neoral dose monitoring with cyclosporine trough levels versus 2-hr postdose levels in stable liver transplant patients [J].
Cantarovich, M ;
Barkun, JS ;
Tchervenkov, JI ;
Besner, JG ;
Aspeslet, L ;
Metrakos, P .
TRANSPLANTATION, 1998, 66 (12) :1621-1627
[2]   Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunction [J].
Cantarovich, M ;
Tzimas, GN ;
Barkun, J ;
Deschenes, M ;
Alpert, E ;
Tchervenkov, J .
TRANSPLANTATION, 2003, 76 (01) :98-102
[3]   Anti-CD25 monoclonal antibody coverage allows for calcineurin inhibitor "holiday" in solid organ transplant patients with acute renal dysfunction [J].
Cantarovich, M ;
Metrakos, P ;
Giannetti, N ;
Cecere, R ;
Barkun, J ;
Tchervenkov, J .
TRANSPLANTATION, 2002, 73 (07) :1169-1172
[4]  
CUERVAMONS V, 1986, HEPATOLOGY, V6, P92
[5]  
DANOVITCH GM, 2001, HDB KIDNEY TRANSPLAN, P62
[6]   Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Part I. [J].
Davis, CL ;
Gonwa, TA ;
Wilkinson, AH .
LIVER TRANSPLANTATION, 2002, 8 (02) :91-109
[7]   Identification of patients best suited for combined liver-kidney transplantation: Part II. [J].
Davis, CL ;
Gonwa, TA ;
Wilkinson, AH .
LIVER TRANSPLANTATION, 2002, 8 (03) :193-211
[8]   Impact of immunosuppressive therapy on recurrence of hepatitis C [J].
Everson, GT .
LIVER TRANSPLANTATION, 2002, 8 (10) :S19-S27
[9]   Chronic renal failure following liver transplantation - A retrospective analysis [J].
Fisher, NC ;
Nightingale, PG ;
Gunson, BK ;
Lipkin, GW ;
Neuberger, JM .
TRANSPLANTATION, 1998, 66 (01) :59-66
[10]   Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation [J].
Fraley, DS ;
Burr, R ;
Bernardini, J ;
Angus, D ;
Kramer, DJ ;
Johnson, JP .
KIDNEY INTERNATIONAL, 1998, 54 (02) :518-524